Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field

BACKGROUND: Bedaquiline (BDQ) tablets are indicated as part of a combination regimen for the treatment of multidrug-resistant TB in adults, adolescents and children. A dispersible tablet formulation is now approved but is not currently available in all settings. The aim of this study was to develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Taneja, R., Nahata, M. C., Scarim, J., Pande, P. G., Scarim, A., Hoddinott, G., Fourie, C. L., Jew, R. K., Schaaf, H. S., Garcia-Prats, A. J., Hesseling, A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983625/
https://www.ncbi.nlm.nih.gov/pubmed/36855042
http://dx.doi.org/10.5588/ijtld.22.0440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983625/
https://www.ncbi.nlm.nih.gov/pubmed/36855042
http://dx.doi.org/10.5588/ijtld.22.0440

Ejemplares similares